中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:(Xican LI)

1.Study on the idiosyncrasy oforganic chemistry textbook for traditional Chinese medicine organic chemistry

Xican LI

Chinese Journal of Medical Education Research 2005;0(06):-

2.Improvement in Soxhlet Extraction with Ore and Shell Hard Chinese Materia Medica

Xican LI ; Kunwang HUANG ; Bingyi LAI ; Wenming LAI

China Pharmacy 2007;0(30):-

3.Identify Polysaccharide in Holothuria atra Jeager by Spectroscopy

Xican LI ; Shaohui DU ; Ling HUANG ; Dongfeng CHEN

China Pharmacy 2005;0(13):-

4.Feature Extraction and Image Recognition of Achyranthes bidentata and Cyathula officinalis

Nai WANG ; Wenbiao LU ; Xiuhua LING ; Lijin LIANG ; Xican LI ; Rui LI

China Pharmacy 2017;28(12):1670-1673

5.Free Radical Scavenging Action of Volatile Oil from Piper longum L.and Its Relationship with Molecular Structure

Xican LI ; Xiaojun ZHAO ; Xueming XIE ; Yuansheng ZHONG ; Chunhua HUANG ; Dongfeng CHEN

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(03):-

6.Research progress on the application of machine learning in predictive modeling of venous thrombo-embolism risk in orthopedics

Ruiting LIU ; Suli XIE ; Weiwei FENG ; Li SONG ; Yi LI ; Mengshuang LYU ; Xican ZHENG

Journal of Xinxiang Medical College 2024;41(6):590-595

7.Construction of the quality evaluation scale of specification of management for humanistic caring in outpatients and its reliability and validity testing

Lixia YUE ; Na CUI ; Xu CHE ; Heng ZHANG ; Hongxia WANG ; Shujie GUO ; Hongling SHI ; Ruiying YU ; Xia XIN ; Xiaohuan CHEN ; Li WANG ; Zhiwei ZHI ; Lei TAN ; Xican ZHENG

Chinese Medical Ethics 2024;37(11):1366-1377

8.Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects.

Wei WEI ; Qingxuan ZENG ; Yan WANG ; Xixi GUO ; Tianyun FAN ; Yinghong LI ; Hongbin DENG ; Liping ZHAO ; Xintong ZHANG ; Yonghua LIU ; Yulong SHI ; Jingyang ZHU ; Xican MA ; Yanxiang WANG ; Jiandong JIANG ; Danqing SONG

Acta Pharmaceutica Sinica B 2023;13(5):2138-2151

9.Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs.

Zhiwen LI ; Zhihao GUO ; Xi LU ; Xican MA ; Xiukun WANG ; Rui ZHANG ; Xinxin HU ; Yanxiang WANG ; Jing PANG ; Tianyun FAN ; Yonghua LIU ; Sheng TANG ; Haigen FU ; Jingpu ZHANG ; Yinghong LI ; Xuefu YOU ; Danqing SONG

Acta Pharmaceutica Sinica B 2023;13(7):3067-3079

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO